Finance Wales' award-winning portfolio sweeps the board at MediWales Awards
Finance Wales’ portfolio companies won five of six industry
awards at the 6th MediWales Awards hosted at Cardiff’s Hilton
Hotel. The prestigious awards recognise excellence in the life
“Finance Wales is committed to investing in innovative companies
and it’s a real pleasure to see so many of our portfolio companies
winning awards this year. MediWales’ awards are highly regarded in
the life sciences sector,” explained Steve Smith, early stage
investments director at Finance Wales.
Outstanding Growth Award
Biotec Services International was recognised for its consistent,
sustainable and profitable growth, winning MediWales’ Outstanding
Growth Award. Two investment rounds totalling £900,000 enabled
Biotec to target new international markets, extending its clinical
supplies service to Asia, Israel and the US.
Industry Judge's Award
Calon Cardio Technology received the Industry Judges’ Award for
its potentially world-leading heart failure treatment. Finance
Wales and Longbow Capital invested £1 million in Calon-Cardio
Technology’s low-cost, minimally-invasive blood pumps.
Find out more about our investment in Calon Cardio
Industry Export Award
Chromogenex won the Industry Export Award for the second year
running after focusing on a strategy of innovation and export-led
growth. The Llanelli-based company manufactures and sells laser and
light technology systems for cosmetic and medical treatments.
Chromogenex used our £1.2 million investment to target key
strategic and emerging markets, including the USA, South Africa,
Europe and Asia.
Find out more about our investment in Chromogenex.
NHS Partnership with Industry Award
The NHS Partnership with Industry Award went to Flexicare
Medical for its collaboration in developing and designing the Hall
Lock, which prevents patients from receiving drugs incorrectly.
Finance Wales has invested a total £550,000 over three funding
Find out more about our investments in Flexicare.
Denbighshire-based Microvisk Technologies won the Start-Up Award
for developing its CoagMax blood testing instrument. Finance Wales
first invested in Microvisk in 2009. In 2010, the company raised
over £8 million from Finance Wales and a strong consortium of